355. Claudia Nari on Inari’s unique advantage + gene editing as a new paradigm in agbioscience

Gene editing in plants – it’s been heralded as the next step-function change in the advancement of agriculture. One Indiana company is advancing the technology fresh off a $144 million venture capital raise. Claudia Nari, Chief Product Officer of Inari, joins today to talk through this historic time for gene editing and biotechnology at large. They get into:  From speed to precision, Claudia lays out the differentiation of gene editing to other types of plant breeding Crops of focus for Inari right now and stresses they’re focused on to enable farmer success The company’s recent venture capital raise, their value proposition and educating investors Inari’s unique advantage (knowing what to do, having the tools to do it and being able to do those at the same time) The status of field trials and what commercialization will look like for Inari Biggest problems in-field to be solved through gene editing – from yield to resource efficiencies Regulatory hurdles and Claudia’s perspective on the acceptance of gene editing as a technology When will Inari technology be in customer fields? And what’s next?